Andrea R Menicucci

5PUBLICATIONS
40CO-AUTHORS
Predictive and prognostic markersTumour immunologyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 24, 2026
Prediction of Anthracycline Benefit in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early-Stage Breast Cancer by the MammaPrint 70-Gene Signature for Patients Enrolled in the FLEX Study.

|Jul 24, 2024
Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial.

Priya Rastogi, Hanna Bandos, Peter C Lucas

|Jan 18, 2024
Prediction of Benefit From Adjuvant Pertuzumab by 80-Gene Signature in the APHINITY (BIG 4-11) Trial.

Ian E Krop, Lorenza Mittempergher, Joseph N Paulson

|Sep 15, 2022
Genomic Classification of HER2-Positive Patients With 80-Gene and 70-Gene Signatures Identifies Diversity in Clinical Outcomes With HER2-Targeted Neoadjuvant Therapy.

Pat W Whitworth, Peter D Beitsch, Mary K Murray

|Apr 27, 2022
Distinct Neoadjuvant Chemotherapy Response and 5-Year Outcome in Patients With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Tumors That Reclassify as Basal-Type by the 80-Gene Signature.

Pat W Whitworth, Peter D Beitsch, James V Pellicane

Pageof 1

Frequent Collaborators

4 joint publications

William Audeh

2 joint publications

James V Pellicane

2 joint publications

Mary K Murray

2 joint publications

Andrew Y Ashikari